A significant reduction in annual well visits and immunizations during the COVID-19 pandemic has led to a vaccination gap among U.S. children and adolescents, especially with the human papillomavirus (HPV) vaccine for cancer prevention.

Monroe Carell Jr. Children’s Hospital at Vanderbilt has launched a study to determine the impact of a predictive model for identifying pediatric patients at risk for developing blood clots or venous thromboembolisms (VTEs).

Two physicians in Vanderbilt’s Department of Pediatrics — James Antoon, MD, PhD, and Shani Jones, MD — have been honored for their work by the American Pediatric Association.

Vanderbilt neonatology team pinpoints signaling pathways involved in the progressive lung fibrosis that occurs in rare genetic diseases.

Rachel Goode, MD, and Jeffrey Hine, MD, are the recipients of the 2021 Geoffrey David Chazen Faculty Award for Innovation in Medical Education.

Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.

For more than two decades, evidence has accrued that the use of volume-targeted ventilation (VTV) results in better outcomes in neonates who require mechanical ventilation in the Neonatal Intensive Care Unit (NICU).